Scientific Leadership

Scientific leadership in clinical trials facilitates study operations through peer-to-peer engagement with investigators

Site performance is transformed by scientific leadership

Scientific leadership in clinical trials facilitates study operations through peer-to-peer engagement with investigators.

  • A scientifically sound, pragmatic approach that informs strong operational delivery
  • Protocol alignment with clinical practice across geographies
  • Motivated and engaged investigators
  • Robust communication conduits between the investigators, study teams, steering committees and the sponsor
Professor Stephen MacMahon

Professor Stephen MacMahon
Principal Director, The George Institute for Global Health

Delivery of our Scientific Leadership model leverages the reputation and extensive global clinical investigator networks of our parent organization, The George Institute of Global Health.

Site performance is transformed by scientific leadership.

In the traditional study operations model, site engagement is typically performed by clinical research associates (CRAs). With George Clinical’s scientific leadership model, we provide a framework that enables active peer-to-peer communication and action pathways between global scientific committee members, national scientific leaders and principal investigators.

Examples of activities within our scientific leadership service model include:

  • Trial design and strategy
  • Publication oversight & writing
  • National Leader selection and appointment
  • Content development for Investigator Meetings
  • Liaison with the various trial committees, National Leaders and operations teams
  • Support site identification and recruitment activities
  • Support patient recruitment and retention activities
  • Advise operational teams on dealing with challenges arising in the trial environment
  • Scientific committee management, such as: selection, appointment, contracting and charter preparations
  • Administrative and communication support between various study committees.
scientific leadership

Professor Vlado Perkovic
Executive Director, The George Institute for Global Health

Meeting
By engaging its scientific leadership, George Clinical is able to recruit international experts to Steering, Adjudication and Data Safety Committees.

George Clinical supports sponsors in the setup of key trial committees by selecting, and contracting world renowned and experienced committee members that we access through our global scientific networks.

George Clinical scientific teams are experts in the establishment and operational management of committees including charter development, meeting organisation and chairing roles.

Investigator Initiated Trials are an essential part of oncology research offering unique insight from a practicing oncologist perspective, and the ability to expand treatment options. Through the IIT design of novel treatment strategies, patients are provided with cutting edge alternative therapies that may not have otherwise have been available to them. George Clinical’s scientific leaders are well placed to identify and address requirements for innovative clinical trials. George Clinical’s strategy is to focus on Phase I and Phase II multi-center, multi-regional oncology trial designs and then continue to collaborate with sponsors to further develop the trial, should that direction be chosen.

George Clinical’s Investigator Initiated Trials are fully supported by the qualified staff of George Clinical who manage all aspects of the project from study design through data lock, analysis, and manuscript. Our team possesses a deep understanding of the clinical landscape and emerging trends in oncology. We have also built strong quality relationships with over 700 experienced investigative oncology sites in both community and academic settings, which help to drive enrolment and ensure that agreed deliverables are met on time and on budget.

Twitter Facebook LinkedIn